Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Ascendis Pharma (ASND) Reports Q2 Loss of EUR0.55/Share
August 29, 2018 4:04 PM EDTAscendis Pharma (NASDAQ: ASND) reported Q2 EPS of (EUR0.55), versus (EUR0.94) reported last year.
For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.
... More